Amprion attends the world’s leading neuroscience conferences, symposiums, and summits.

2024 Industry Events

Amprion connects with breakthrough-seeking medical and research professionals to crack the code on precision medicine for Alzheimer’s, Parkinson’s, Lewy body dementia, and other neurodegenerative diseases through early detection. We look forward to meeting you!

AD/PD 2024 logo

AD/PD 2024 International Conference

March 5-9, 2024 | Lisbon

AAN 2024 meeting logo


April 13-18, 2024 | Denver

AAIC conference logo

Alzheimer's Association International Conference®

July 28-August 1, 2024 | Philadelphia

International Congress of Parkinson's Disease and Movement Disorders®

Sep 27-Oct 1, 2024 | Philadelphia

Please Note: Important Billing Info

To improve patient access to the SYNTap® Biomarker CSF Test, Amprion offers the following billing options:

  • List price of $1500, with courtesy billing for both Medicare and private insurance.
  • An affordable self-pay price of $995 (patients may qualify for financial assistance and/or interest-free payment options).
  • Prices are effective as of January 1, 2024, and are subject to change.

Please note: Amprion is a Medicare participating provider, however, the SYNTap test does not currently have Medicare coverage determination. Also, Amprion is not yet in network with most insurers.

The SYNTap Biomarker CSF Test has been issued a dedicated CPT® PLA code to be used when billing: 0393U.

For additional information, please visit our billing page.